Solve Therapeutics Stock

HealthTech

Solve Therapeutics operates a biotechnology platform focused on creating innovative antibody-drug conjugates. The company specializes in developing these conjugates and bispecific therapeutics with enhanced selectivity and optimized payload delivery. Additionally, Solve Therapeutics is working on novel patient-selection diagnostics to assist medical professionals in addressing unmet patient needs, ultimately aiming to enhance patients' lives.